News Conference News TCT 2025 Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE Caitlin E. Cox October 26, 2025
News Conference News ESC 2025 HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients Caitlin E. Cox September 01, 2025
News Conference News EuroPCR 2025 Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI Michael O'Riordan May 21, 2025
News Conference News ISC 2025 Stroke Thrombectomy Doesn’t Help for Blockages in Smaller Vessels Todd Neale February 06, 2025
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Conference News TCT 2024 PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE Todd Neale October 29, 2024
News Conference News ISC 2024 Radial Access for Acute Stroke Interventions Takes Longer, No Safety Gains Todd Neale February 12, 2024
News Conference News ISC 2024 Thrombectomy Advantage for Large-Core Strokes Widens Over 12 Months: TESLA Todd Neale February 09, 2024
News Conference News ISET 2024 AI Tools to Meet Every Need? The Future of Vascular Medicine Caitlin E. Cox February 02, 2024
News Conference News ISET 2024 Will IVUS Ever Take Off in Peripheral Vascular Interventions? Caitlin E. Cox January 31, 2024
News Conference News ISET 2024 AI in Pulmonary Embolism: ‘Transformative’ for Patient Care Caitlin E. Cox January 30, 2024
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
News Conference News SCAI 2023 FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy L.A. McKeown May 21, 2023
News Conference News ISC 2023 Lower BP Targets After Stroke Thrombectomy Don’t Seem to Help: BEST-II Todd Neale February 10, 2023
News Conference News STS 2023 Earlier, More-Active Surgeon Involvement Needed in PE Care: AHA Yael L. Maxwell January 27, 2023
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years L.A. McKeown November 03, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News VIVA 2021 EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions L.A. McKeown October 12, 2021
News Conference News VIVA 2020 As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice L.A. McKeown November 27, 2020